433 results on '"Roobol, Monique J."'
Search Results
2. Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe
3. MP31-01 OPTIMIZING DETECTION AND PREDICTION OF PROSTATE CANCER AFTER POSITIVE MRI AND NEGATIVE BIOPSIES
4. Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin’s Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam. Eur Urol 2024;85:74–81
5. How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?
6. Evolution of European prostate cancer screening protocols and summary of ongoing trials
7. Comparison of Magnetic Resonance Imaging–Based Risk Calculators to Predict Prostate Cancer Risk
8. A COMPARISON OF MAGNETIC RESONANCE IMAGING-BASED RISK CALCULATORS TO PREDICT PROSTATE CANCER RISK IN EUROPEAN AND NORTH AMERICAN COHORTS
9. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
10. Lymphoceles after pelvic lymph node dissection during robot-assisted radical prostatectomy
11. Re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547–58
12. A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer
13. Performance of magnetic resonance imaging‐based prostate cancer risk calculators and decision strategies in two large European medical centres
14. Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U
15. Urinary Incontinence and Sexual Function After the Introduction of NeuroSAFE in Radical Prostatectomy for Prostate Cancer
16. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
17. Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data
18. Prostatakrebs-Früherkennung: Stand und Evidenz der Methoden
19. Screening of Prostate Cancer
20. Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry
21. A literature review to understand health literacy in men with prostate cancer on active surveillance
22. The Europa Uomo Patient Reported Outcome Study 2.0—Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making
23. The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
24. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries
25. External validation of the Rotterdam Prostate Cancer Risk Calculator within a Dutch high-risk clinical cohort
26. Active Surveillance for Prostate Cancer: Past, Current, and Future Trends
27. Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps
28. Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer
29. Supplementary Materials and Methods from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
30. Supplementary Figure Legends from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
31. Supplementary Tables 1 through 8 and Supplementary Figures 1 through 15 from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
32. Data from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
33. Supplementary Figure Legends from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
34. Data from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
35. Supplementary Tables 1 through 8 and Supplementary Figures 1 through 15 from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
36. Supplementary Materials and Methods from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
37. Early detection and screening for prostate cancer
38. Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator
39. Interaction of MRI and active surveillance in prostate cancer: Time to re-evaluate the active surveillance inclusion criteria
40. The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates
41. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting
42. The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men
43. Shifting risk‐stratified early prostate cancer detection to a primary healthcare setting
44. Sexual and urinary function in prostate cancer clinical studies and the Europa Uomo Patient Reported Outcome Study: does it match?
45. A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer—Data from the International Multicenter Prospective PRIAS Study
46. External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort
47. Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection
48. Improving Guideline Adherence in Urology
49. How Should Patients on Active Surveillance Be Followed?
50. Can We Screen and Still Reduce Overdiagnosis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.